Literature DB >> 9472883

The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks.

J Broderick1, T Brott, R Kothari, R Miller, J Khoury, A Pancioli, J Gebel, D Mills, L Minneci, R Shukla.   

Abstract

BACKGROUND AND
PURPOSE: The Greater Cincinnati/Northern Kentucky Stroke Study was designed to be the first large, population-based metropolitan study of temporal trends in stroke incidence rates and outcome within a biracial population.
METHODS: We are identifying all hospitalized and autopsied cases of stroke and transient ischemic attack (TIA) among the 1.3 million inhabitants of a five-county region of Greater Cincinnati/Northern Kentucky for the period 7/1/93-6/30/94. We have already prospectively monitored for out-of-hospital stroke and TIAs for this same time period at 128 screening sites, including a random sample of all primary care physicians and nursing homes in the region. We have already identified all hospitalized and autopsied cases of stroke and TIA among blacks for 1/1/93-6/30/93 and report preliminary incidence rates for this 6-month period.
RESULTS: The overall incidence rate for all first-ever hospitalized or autopsied stroke (excluding TIAs) among blacks in the Greater Cincinnati region was 288 per 100000 (95% CI, 250 to 325, age- and sex-adjusted to 1990 US population). The overall incidence rate for first-ever and recurrent stroke (excluding TIAs) was 411 per 100000 (95% CI, 366 to 456). By comparison, the overall incidence rate of first-ever stroke among whites in Rochester, Minn, during the period 1985-1989 was 179 per 100000 (95% CI, 164 to 194, age- and-sex adjusted to 1990 US population). The incidence rates among blacks in Greater Cincinnati were substantially greater than the rates among whites in Rochester, Minn, for all age categories except ages 75 and older, for which the rates were similar.
CONCLUSIONS: We conservatively estimate that 731100 first-ever or recurrent strokes occurred in the United States during 1996. Studies of first-ever as well as total stroke among biracial and representative populations are critical for understanding temporal trends in the incidence rate and the burden of stroke in the US population.

Entities:  

Mesh:

Year:  1998        PMID: 9472883     DOI: 10.1161/01.str.29.2.415

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  164 in total

Review 1.  Constraint-induced movement therapy to enhance recovery after stroke.

Authors:  E Taub; D M Morris
Journal:  Curr Atheroscler Rep       Date:  2001-07       Impact factor: 5.113

2.  Deaths from stroke in US young adults, 1989-2009.

Authors:  Sharon N Poisson; David Glidden; S Claiborne Johnston; Heather J Fullerton
Journal:  Neurology       Date:  2014-10-31       Impact factor: 9.910

3.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

4.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

5.  Patients living in impoverished areas have more severe ischemic strokes.

Authors:  Dawn Kleindorfer; Christopher Lindsell; Kathleen A Alwell; Charles J Moomaw; Daniel Woo; Matthew L Flaherty; Pooja Khatri; Opeolu Adeoye; Simona Ferioli; Brett M Kissela
Journal:  Stroke       Date:  2012-07-05       Impact factor: 7.914

6.  Privately insured medical patients are more likely to have a head CT.

Authors:  Emily M Fortin; Jerry Fisher; Sheng Qiu; Charlene Irvin Babcock
Journal:  Emerg Radiol       Date:  2016-07-20

7.  First results in an MR imaging--compatible canine model of acute stroke.

Authors:  A Shaibani; S Khawar; W Shin; T A Cashen; B Schirf; M Rohany; S Kakodkar; T J Carroll
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

8.  Ethnic difference in the relationship between acute inflammation and serum ferritin in US adult males.

Authors:  Y Pan; R T Jackson
Journal:  Epidemiol Infect       Date:  2007-03-22       Impact factor: 2.451

9.  Risk factors associated with major cerebrovascular complications after intracranial stenting.

Authors:  F Nahab; M J Lynn; S E Kasner; M J Alexander; R Klucznik; O O Zaidat; J Chaloupka; H Lutsep; S Barnwell; M Mawad; B Lane; M I Chimowitz
Journal:  Neurology       Date:  2009-03-18       Impact factor: 9.910

10.  Leukocyte-borne α(1,3)-fucose is a negative regulator of β2-integrin-dependent recruitment in lung inflammation.

Authors:  Alexander Buffone; Mehrab Nasirikenari; Charles T Manhardt; Amit Lugade; Paul N Bogner; Robert Sackstein; Yasmin Thanavala; Sriram Neelamegham; Joseph T Y Lau
Journal:  J Leukoc Biol       Date:  2016-08-26       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.